Yanfen Niu

625 total citations
29 papers, 515 citations indexed

About

Yanfen Niu is a scholar working on Molecular Biology, Nephrology and Inorganic Chemistry. According to data from OpenAlex, Yanfen Niu has authored 29 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Nephrology and 7 papers in Inorganic Chemistry. Recurrent topics in Yanfen Niu's work include Gout, Hyperuricemia, Uric Acid (11 papers), Vanadium and Halogenation Chemistry (7 papers) and Inflammasome and immune disorders (4 papers). Yanfen Niu is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (11 papers), Vanadium and Halogenation Chemistry (7 papers) and Inflammasome and immune disorders (4 papers). Yanfen Niu collaborates with scholars based in China and Hong Kong. Yanfen Niu's co-authors include Lihui Gao, Hua Lin, Ling Li, Ming‐Jin Xie, Weiping Liu, Wenyong Xiong, Ji‐Kai Liu, Ling Li, Ling Li and Wei Lu and has published in prestigious journals such as Polymer, American Journal of Physiology-Cell Physiology and European Journal of Pharmacology.

In The Last Decade

Yanfen Niu

28 papers receiving 508 citations

Peers

Yanfen Niu

NEPHR

CAM

PHARM

Amritpal Singh India

Phikelelani Ngubane South Africa

Yichao Wu China

Xian Zheng China

Lian Yin China

Joana D’Árc Castania Darin Brazil

Xiaolong Hou China

Farah Khan India

Juanjuan Zhao China

Amritpal Singh India

Yanfen Niu

94 ×0.5

25 ×0.2

NEPHR

80 ×0.8

CAM

17 ×0.2

115 ×1.4

PHARM

Citations per year, relative to Yanfen Niu Yanfen Niu (= 1×) peers Amritpal Singh

Countries citing papers authored by Yanfen Niu

Since Specialization

Citations

This map shows the geographic impact of Yanfen Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfen Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfen Niu more than expected).

Fields of papers citing papers by Yanfen Niu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanfen Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfen Niu. The network helps show where Yanfen Niu may publish in the future.

Co-authorship network of co-authors of Yanfen Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanfen Niu. A scholar is included among the top collaborators of Yanfen Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanfen Niu. Yanfen Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yong, et al.. (2022). Ginkgetin promotes proliferation and migration of Schwann cells via PIGF/p38 MAPK signaling pathway. Tissue and Cell. 79. 101967–101967. 4 indexed citations

Niu, Yanfen, Hongjian Li, Qiang Li, et al.. (2020). Olsalazine Sodium Increases Renal Urate Excretion by Modulating Urate Transporters in Hyperuricemic Animals. Biological and Pharmaceutical Bulletin. 43(11). 1653–1659. 1 indexed citations

Niu, Yanfen, et al.. (2020). Eriocalyxin B Inhibits Adipogenesis in 3T3-L1 Adipocytes by Cell Cycle Arrest. Natural Products and Bioprospecting. 10(3). 131–140. 12 indexed citations

Lin, Hua, Cai‐Xia Tu, Yanfen Niu, et al.. (2019). Dual actions of norathyriol as a new candidate hypouricaemic agent: uricosuric effects and xanthine oxidase inhibition. European Journal of Pharmacology. 853. 371–380. 17 indexed citations

Yang, Hua, Wenwei Bai, Lihui Gao, et al.. (2018). Mangiferin alleviates hypertension induced by hyperuricemia via increasing nitric oxide releases. Journal of Pharmacological Sciences. 137(2). 154–161. 28 indexed citations

Niu, Yanfen, Hongjian Li, Lihui Gao, et al.. (2017). Old drug, new indication: Olsalazine sodium reduced serum uric acid levels in mice via inhibiting xanthine oxidoreductase activity. Journal of Pharmacological Sciences. 135(3). 114–120. 12 indexed citations

Gao, Yuan, Yanfen Niu, Fei Wang, et al.. (2016). Clerodane Diterpenoids with Anti-hyperglycemic Activity from Tinospora crispa. Natural Products and Bioprospecting. 6(5). 247–255. 20 indexed citations

Niu, Yanfen, Jia Liu, Hai‐Yang Liu, et al.. (2016). Hypouricaemic action of mangiferin results from metabolite norathyriol via inhibiting xanthine oxidase activity. Pharmaceutical Biology. 54(9). 1680–1686. 26 indexed citations

Wei, Kun, Gangqiang Wang, Xue Bai, et al.. (2015). Structure-Based Optimization and Biological Evaluation of Pancreatic Lipase Inhibitors as Novel Potential Antiobesity Agents. Natural Products and Bioprospecting. 5(3). 129–157. 25 indexed citations

10.

Yang, Hua, Lihui Gao, Yanfen Niu, et al.. (2015). Mangiferin Inhibits Renal Urate Reabsorption by Modulating Urate Transporters in Experimental Hyperuricemia. Biological and Pharmaceutical Bulletin. 38(10). 1591–1598. 42 indexed citations

11.

Wang, Fang, Juming Yan, Yanfen Niu, et al.. (2013). Mangiferin and its aglycone, norathyriol, improve glucose metabolism by activation of AMP-activated protein kinase. Pharmaceutical Biology. 52(1). 68–73. 35 indexed citations

12.

Niu, Yanfen, Wei Lu, Lihui Gao, et al.. (2012). Reducing effect of mangiferin on serum uric acid levels in mice. Pharmaceutical Biology. 50(9). 1177–1182. 26 indexed citations

13.

Xie, Ming‐Jin, Ling Li, Xiaoda Yang, et al.. (2010). A new insulin-enhancing agent: [N,N′-bis(4-hydroxysalicylidene)-o-phenylene-diamine]oxovanadium(IV) and its permeability and cytotoxicity. European Journal of Medicinal Chemistry. 45(6). 2327–2335. 21 indexed citations

14.

Xie, Ming‐Jin, Yanfen Niu, Xiaoda Yang, et al.. (2010). Effect of the chloro-substitution on lowering diabetic hyperglycemia of vanadium complexes with their permeability and cytotoxicity. European Journal of Medicinal Chemistry. 45(12). 6077–6084. 34 indexed citations

15.

Niu, Yanfen, Hua‐Jie Zhu, Jia Liu, et al.. (2010). 3,5,2′,4′-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor. Chemico-Biological Interactions. 189(3). 161–166. 42 indexed citations

16.

Niu, Yanfen, et al.. (2008). Bis(<I>α</I>-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes. Journal of Pharmacy and Pharmacology. 60(10). 1335–1340. 4 indexed citations

17.

Liu, Weiping, et al.. (2008). Bis(α-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes. Journal of Pharmacy and Pharmacology. 60(10). 1335–1340. 11 indexed citations

18.

Gao, Lihui, Yanfen Niu, Weiping Liu, et al.. (2007). The antilipolytic action of bis(α-furancarboxylato)oxovanadium(IV) in adipocytes. Clinica Chimica Acta. 388(1-2). 89–94. 10 indexed citations

19.

Niu, Yanfen, Weiping Liu, Ming‐Jin Xie, et al.. (2007). Effects of bis(α-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats. European Journal of Pharmacology. 572(2-3). 213–219. 22 indexed citations

20.

Xie, Ming‐Jin, et al.. (2007). In vivo insulin-mimetic activity of [N,N′-1,3-propyl-bis(salicyladimine)]oxovanadium(IV). European Journal of Medicinal Chemistry. 42(6). 817–822. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact